🇺🇸 FDA
Patent

US 7582289

Viruses for the treatment of cellular proliferative disorders

granted A61KA61K35/13A61K35/76

Quick answer

US patent 7582289 (Viruses for the treatment of cellular proliferative disorders) held by ONCOLYTICS BIOTECH INC. expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ONCOLYTICS BIOTECH INC.
Grant date
Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K35/13, A61K35/76, A61K35/761, A61K38/13